- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: FDG Positron emission tomography (PET) scan
Total 1036 results
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Stage III Thyroid Gland Papillary Carcinoma | Stage IV Thyroid Gland Papillary Carcinoma | Stage III Thyroid Gland Follicular Carcinoma | Stage IV Thyroid Gland Follicular CarcinomaUnited States
-
Mayo ClinicRecruitingClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Human Papillomavirus-Related Carcinoma | Locally Advanced Oropharyngeal CarcinomaUnited States
-
University of UtahTerminatedMalignant NeoplasmUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedLung Cancer | Metastatic CancerUnited States
-
Chase Pharmaceuticals Corporation, an affiliate...Withdrawn
-
Centre Henri BecquerelU918 ( Inserm unit)CompletedNon Hodgkin LymphomaFrance
-
National Cancer Institute (NCI)TerminatedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Anaplastic Thyroid Cancer | Stage III Follicular Thyroid Cancer | Stage III Papillary Thyroid CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Breast AdenocarcinomaUnited States
-
Rigshospitalet, DenmarkUnknownUrinary Bladder NeoplasmsDenmark
-
University of FloridaFlorida Academic Cancer Center AllianceCompleted
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterRecruitingNeuroendocrine TumorsUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditionsUnited States, Puerto Rico
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent Prostate CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
King's College Hospital NHS TrustRecruitingPheochromocytoma | ParagangliomaUnited Kingdom
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Sebastian ZschaeckHelmholtz Zentrum Dresden Rossendorf, Dresden, GermanyRecruiting
-
Stanford UniversityGE HealthcareCompleted
-
Piramal Imaging LimitedCompletedAlzheimer's Disease (AD)France
-
NYU Langone HealthYale UniversityTerminatedTrauma | Post-traumatic Stress Disorder (PTSD)United States
-
NYU Langone HealthYale University; Icahn School of Medicine at Mount SinaiTerminated
-
NYU Langone HealthYale UniversityTerminatedAnhedonia | Major Depressive DisorderUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Metastatic Kidney CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVA Lip and Oral... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, FemaleUnited States
-
Washington University School of MedicineTerminated
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Albert KoongCompleted
-
Wuhan Union Hospital, ChinaRecruitingMalignant NeoplasmChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingFollicular LymphomaUnited States
-
General University Hospital, PragueCharles University, Czech RepublicRecruitingCervical Cancer | Lymph Node MetastasisCzechia
-
Zhongnan HospitalRecruitingMalignant Neoplasm | PET/CT | Fibroblast Activation Protein InhibitorChina
-
Jonsson Comprehensive Cancer CenterNational Institutes of Health (NIH)CompletedLymphoma | Lymphoma, Non-Hodgkin | Large B Cell Diffuse LymphomaUnited States, Germany
-
Peking Union Medical College HospitalRecruiting
-
Dae Hyuk MoonRecruitingVenous ThrombosisKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingProstate CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Promyelocytic Leukemia With PML-RARAUnited States
-
University Hospital, BordeauxCompleted
-
University of California, DavisCompletedNonalcoholic Steatohepatitis (NASH) | Non-Alcoholic Fatty Liver Disease (NAFLD)United States
-
University Hospital, BordeauxRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingMetastatic Urothelial Carcinoma | Unresectable Urothelial Carcinoma
-
National Cancer Institute (NCI)SuspendedPathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8United States
-
NRG OncologyNational Cancer Institute (NCI); Canadian Cancer Trials GroupSuspendedStage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 | Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 | Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8United States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States